Joggy K George MD FACC FSCAI
[Pronunciation: Joe-G]
Heart Failure & Transplantation, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Cardiac Critical Care
President, Texas Heart and Vascular Specialists
Join to View Full Profile
6624 Fannin StSuite 1970Houston, TX 77030
Phone+1 713-797-1111
Fax+1 713-790-0008
Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Interventional Cardiology, 2013 - 2014- Baylor College of Medicine/Texas Heart Institute/Baylor St Luke's Medical CenterFellowship, Cardiovascular Disease, 2010 - 2013
- Baylor College of Medicine/St Luke's Episcopal HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2008 - 2009
Maimonides Medical CenterResidency, Internal Medicine, 2005 - 2008
Ross University School of MedicineClass of 2005
Certifications & Licensure
TX State Medical License 2008 - 2025
NY State Medical License 2008 - 2010
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
National Board of Physicians and Surgeons Advanced Heart Failure and Transplant- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Interventional Cardiology
National Board of EchocardiographyComprehensive Echocardiography
Clinical Trials
- Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure. Start of enrollment: 2014 Feb 14
- Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure Start of enrollment: 2015 Oct 01
- Stem Cell Injection in Cancer Survivors Start of enrollment: 2016 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Effect of Preoperative Mitral Regurgitation on LVAD Outcomes in Patients with Elevated Pulmonary Vascular Resistance.Riyad Yazan Kherallah, Harveen K Lamba, Andrew B Civitello, Ajith P Nair, Leo Simpson
Cardiovascular Drugs and Therapy. 2024-08-20 - 1 citationsExtracorporeal Membrane Oxygenation for COVID-19: Collaborative Experience From the Texas Medical Center in Houston With 2 Years Follow-Up.Bindu Akkanti, Erik E Suarez, Erika R O'Neil, Aniket S Rali, Rahat Hussain
ASAIO Journal. 2022-12-01 - Echocardiography and Nuclear Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis.Aaron L Bush, Salman J Bandeali, Warren Moore, Joggy K George
Texas Heart Institute Journal. 2021-11-01
Professional Memberships
- Fellow
- Member
- Fellow
- Texas Heart Institute Cardiac SocietyPresident
- International Society of Heart and Lung TransplantationMember
- Heart Failure Society of AmericaMember
External Links
- Texas Heart and Vascular Specialistshttp://www.thvs.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
